The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global medical foods for inborn errors of metabolism market, as per The Business Research Company’s report for 2023, anticipates an increase from $2.39 billion in 2022 to $2.72 billion in 2023, showing a 13.5% CAGR. By 2027, it is forecasted to reach $4.31 billion with a 12.1% CAGR.

North America held the largest medical foods for inborn errors of metabolism market share.

Medical Foods For Inborn Errors Of Metabolism Market Driver

The growth of medical foods for inborn errors of metabolism market is expected to be propelled by the increase in genetic (inherited) disorders. Genetic (inherited) disorders result from deviations in DNA sequence, requiring specialized nutrition to address unique metabolic needs, preventing deficits, and promoting well-being. For example, Medline Plus reported in May 2021 that 1 in 200,000 individuals in the US are diagnosed with syndrome A each year due to a gene variant, and 15,000 patients worldwide have been diagnosed with syndrome B. Hence, the expansion of genetic (inherited) disorders is a key driver for the medical foods for inborn errors of metabolism market.

View More On The Medical Foods For Inborn Errors Of Metabolism Market Report 2023 – https://www.thebusinessresearchcompany.com/report/medical-foods-for-inborn-errors-of-metabolism-global-market-report

Key Medical Foods For Inborn Errors Of Metabolism Market Segments

The global medical foods for inborn errors of metabolism market is segmented –

1) By Product: Amino Acid, Glytactin with GMP Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula with Iron, Low Protein Food, Other Products

2) By Diseases: Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Homocystinuria, Methylmalonic Acidemia, Organic Acidurias, Propionic Acidemia, Isovaleric Acidemia, Disorders of Leucine Metabolism, Glutaric Acidemia Type I Renal Disease, Other Diseases

3) By Age Group: Infants, Weaning, Adolescent, Adults

4) By Forms: Powder, Liquids, Gels, Other Forms

5) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Drugs Stores, Online Pharmacies, Other Distribution Channels

Medical Foods For Inborn Errors Of Metabolism Market Prominent Players

Major players in the medical foods for inborn errors of metabolism market are BASF SE, Abbott Laboratories Inc, Danone SA, Bristol-Myers Squibb Co, Meiji Holdings Co Ltd., Nestlé Health Science S.A., Ajinomoto Corporation, Mount Sinai Health System, BioMarin Pharmaceutical Inc, Gerber Products Company, Metagenics Inc., Vitaflo International, SHS International Limited, Merck $ Co Inc., Galen Medical Group, Applied Nutrition Corp., Primus Pharmaceuticals Inc., Reckitt Benckiser Group Plc, Ener-G Foods Inc, Pristine Organics Pvt. Ltd., Cymbiotika LLC, BC Children’s Hospital, NutriScience Innovations LLC, and Solace Nutrition LLC.

Request A Sample Of The Global Medical Foods For Inborn Errors Of Metabolism Market Report 2023:

https://www.thebusinessresearchcompany.com/sample_request?id=12161&type=smp

Prominent Medical Foods For Inborn Errors Of Metabolism Market Trend

Product innovation is a prominent trend in the medical food for inborn errors in the metabolism market. Major companies in this sector are focused on developing innovative products to bolster their market position. For instance, in December 2021, SFI Health, a Swiss natural healthcare company, launched EQUAZEN PRO, a specially formulated medical food for specific nutritional requirements of omega fatty acids in the dietary treatment of conditions. EQUAZEN PRO supports healthy fatty acid metabolism and is scientifically proven to enhance brain health in children and adolescents with ADHD and related neurodiverse conditions, providing nutritional support. It contains sustainably sourced fish oils and evening primrose oil, with a capsule shell design ensuring gastro resistance to prevent fishy taste or reflux by delaying the transfer of fish oil from the stomach to the intestine.

The Medical Foods For Inborn Errors Of Metabolism Global Market Report 2023  provides comprehensive insights on the medical foods for inborn errors of metabolism market size, trends and drivers, opportunities, strategies, and competitor analysis. The countries covered in the medical foods for inborn errors of metabolism market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –

Metabolomics Global Market Report 2023

Bioanalytical Testing Services Global Market Report 2023

Bone And Mineral Diagnostic Testing Global Market Report 2023

Learn More About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model